Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
amitriptyline + propranolol
- Development stage
- Unknown
- Lead developer
- Centaur Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Amitriptyline + propranolol** is an oral fixed-dose combination of two small molecules used principally for migraine prophylaxis. Amitriptyline is a tricyclic antidepressant that inhibits neuronal norepinephrine and serotonin reuptake, while propranolol is a nonselective beta-adrenergic receptor blocker. The complementary pharmacology is intended to reduce migraine frequency and may be useful where migraine coexists with tension-type headache features. Marketed Indian products include extended-release tablet presentations such as Health N U's AmNuriteBeta. ([1mg.com](https://www.1mg.com/generics/amitriptyline-propranolol-405636))
- Brand names
- AM-BETAAmnotript-PRAmNuriteBetaEtosis PGaltrip BetaPro ATTriptamin PRTripbetaTriptololTryptojam-Pro
- Other names
- amitriptyline + propranololamitriptyline/propranolol
02
Targets
SERT (Sodium-dependent serotonin transporter)ADRB2 (β2)HRH1 (Histamine H1 Receptor)ADRA1A (α1A)ADRB1 (β1)mAChR (Muscarinic acetylcholine receptors)NET (Norepinephrine Transporter)
Beyond the preview
Go deeper on amitriptyline + propranolol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on amitriptyline + propranolol.